We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$484M
AUM Growth
+$33.4M
Cap. Flow
+$5.94M
Cap. Flow %
1.23%
Top 10 Hldgs %
35.68%
Holding
242
New
81
Increased
34
Reduced
44
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Financials 18.99%
3 Healthcare 18.33%
4 Consumer Staples 11.91%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
226
DELISTED
Monsanto Co
MON
$0 ﹤0.01%
+1
New +$111
LVNTA
227
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$0 ﹤0.01%
+1
New +$43
BIVV
228
DELISTED
Bioverativ Inc. Common Stock
BIVV
$0 ﹤0.01%
+4
New +$197
BHI
229
DELISTED
Baker Hughes
BHI
$0 ﹤0.01%
+5
New +$304
YHOO
230
DELISTED
Yahoo Inc
YHOO
$0 ﹤0.01%
+8
New +$357
AWH
231
DELISTED
Allied World Assurance Co Hld Lt
AWH
$0 ﹤0.01%
+9
New +$479
ATVI
232
DELISTED
Activision Blizzard
ATVI
$0 ﹤0.01%
6
SHPG
233
DELISTED
Shire pic
SHPG
-22
Closed -$4K
GCVRZ
234
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
+3
New +$1
FRP
235
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
$0 ﹤0.01%
75

Similar funds

Kelly Lawrence W & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Kelly Lawrence W & Associates held 242 positions worth $484M, up 7.4% from $451M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates's Q1 2017 filing shows 81 new, 34 increased, 44 reduced and 12 closed positions. Its largest new stake was Bright Horizons: 175,040 shares worth $12.7M. The largest sale was Qualcomm, an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Kelly Lawrence W & Associates's largest Q1 2017 buy was Bright Horizons: 175,040 shares worth $12.7M.
  • Kelly Lawrence W & Associates added most to Regeneron Pharmaceuticals in Q1 2017, an estimated $9.04M increase.
  • Kelly Lawrence W & Associates's biggest Q1 2017 reduction was Qualcomm, cutting an estimated $13.6M.
  • Kelly Lawrence W & Associates fully exited Flowserve in Q1 2017, selling an estimated $2.21M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $484M portfolio in Q1 2017.
  • Kelly Lawrence W & Associates opened 81 new positions and closed 12 in Q1 2017.
  • Kelly Lawrence W & Associates's portfolio value rose 7.4% quarter-over-quarter to $484M.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2017, filed 15 May 2017.